Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 11, Issue 3, 2005, Pages 314-321

  Itzkowitz, Steven H ^a   Present, Daniel H ^a   Binder, Vibeke ^b   Boland, C Richard ^c   Brentnall, Teresa A ^d   Chutkan, Robynne K ^e   Cogan, Michael P ^f   Ekbom, Anders ^g   Ezaki, Toshihiko ^h   Haggitt, Rodger C ^d   Hisamatsu, Tadakazu ^h   Karlén, Per ^g   Korelitz, Burton I ⁱ   Lashner, Bret A ^j   Loeb, Lawrence ^d   Lennard Jones, John ^k   Lofberg, Robert ^l   Loftus Jr , Edward V ^m  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c UCSD MEDICAL CENTER   (United States)

^d UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^e GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^f Cogan and McNabola PC ^*  (United States)

^g KAROLINSKA INSTITUTE   (Sweden)

^h KEIO UNIVERSITY HOSPITAL   (Japan)

ⁱ LENOX HILL HOSPITAL   (United States)

^j LERNER RESEARCH INSTITUTE   (United States)

^k Huddinge University Hospital ^*

^l KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^m MAYO CLINIC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; FOLIC ACID; URSODEOXYCHOLIC ACID;

CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CHROMOENDOSCOPY; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; CONFERENCE PAPER; CONSENSUS; CROHN DISEASE; DISEASE CLASSIFICATION; DISEASE DURATION; EARLY DIAGNOSIS; ENTERITIS; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; HUMAN; IDIOPATHIC DISEASE; INTESTINE BIOPSY; INTESTINE POLYP; ONSET AGE; PATHOLOGICAL ANATOMY; PATIENT SELECTION; POLYPECTOMY; PRACTICE GUIDELINE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROCTOCOLECTOMY; RISK FACTOR; ULCERATIVE COLITIS;

EID: 20144388645     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MIB.0000160811.76729.d5     Document Type: Conference Paper

References (39)

1. Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology. 2004; 126:1634-1648.
2. Karlen P, Kornfeld D, Brostrom O, et al. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut. 1998;42:711-714.
3. Eaden J, Abrams K, Ekbom A, et al. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther. 2000;14: 145-153.
4. Eaden JA, Mayberry JF. Guidelines for screening and surveillance of asymptomatic colorectal cancer patients with inflammatory bowel disease. Gut. 2002;51(Suppl V):v10-v12.
5. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (Update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2004;99:1371-1385.
6. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale - update based on new evidence. Gastroenterology. 2003;124:544-560.
7. Bernstein CN, Blanchard JF, Kliewer E, et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001;91: 854-862.
8. Sachar DB. Cancer in Crohn's disease: dispelling the myths. Gut. 1994; 35:1507-1508.
9. Eaden J, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526-535.
10. Mathy C, Schneider K, Chen YY, et al. Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis. Inflamm Bowel Dis. 2003;9:351-355.
11. Jayaram H, Satsangi J, Chapman RW. Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction? Gut. 2001;48:430-434.
12. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer: a population-based study. N Engl J Med. 1990;323:1228-1233.
13. Prior P, Gyde SN, Macartney JC, et al. Cancer morbidity in ulcerative colitis. Gut. 1982;23:490-497.
14. Askling J, Dickman PW, Karlen P, et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology. 2001; 120:1356-1362.
15. Nuako KW, Ahlquist DA, Mahoney DW, et al. Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. Gastroenterology. 1998;115:1079-1083.
16. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:451-459.
17. Pardi DS, Loftus EV Jr, Kremers WK, et al. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology. 2003; 124:889-893.
18. Tung BY, Emond MJ, Haggitt RC, et al. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med. 2001;134: 89-95.
19. Connell WR, Lennard-Jones JE, Williams CB, et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology. 1994;107:934-944.
20. Lim CH, Dixon MF, Vail A, et al. Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut 2003;52:1127-1132.
21. Lashner BA, Provencher KS, Bozdech JM, et al. Worsening risk for the development of dysplasia or cancer in patients with chronic ulcerative colitis. Am J Gastroenterol. 1995;90:377-380.
22. Rubin CE, Haggitt RC, Burmer GC, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology. 1992;103:1611-1620.
23. Rutter MD, Saunders BP, Wilkinson KH, et al. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc. 2004;60: 334-339.
24. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet. 1994; 343:71-74.
25. Woolrich AJ, DaSilva MD, Korelitz BI. Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia. Gastroenterology. 1992;103:431-438.
26. Ullman TA, Loftus EV Jr, Kakar S, et al. The fate of low grade dysplasia in ulcerative colitis. Am J Gastroenterol. 2002;97:922-927.
27. Ullman TA, Croog T, Harpaz N, et al. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology. 2003;125:1311-1319.
28. Befrits R, Ljung T, Jaramillo E, et al. Low-grade dysplasia in extensive, long-standing inflammatory bowel disease; a follow-up study. Dis Colon Rectum. 2002;45:615-620.
29. Rubin PH, Friedman S, Harpaz N, et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology. 1999;117:1295-1300.
30. Engelsgjerd M, Farraye FA, Odze RD. Polypectomy may be adequate treatment for adenoma-like dysplastic, lesions in chronic ulcerative colitis. Gastroenterology. 1999;117:1288-1294.
31. Odze RD, Farraye FA, Hecht JL, et al. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol. 2004;2:534-541.
32. Friedman S, Rubin PH, Bodian C, et al. Screening and surveillance colonoscopy in chronic Crohn's colitis. Gastroenterology 2001;120:820-826.
33. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14:931-968.
34. Gumaste V, Sachar DB, Greenstein AJ. Benign and malignant colorectal strictures in ulcerative colitis. Gut. 1992;33:938-941.
35. Reiser JR, Waye JD, Janowitz HD, et al. Adenocarcinoma in strictures of ulcerative colitis without antecedent dysplasia by colonoscopy. Am J Gastroenterol. 1994;89:119-122.
36. Saunders BP, Brown GJ, Lemann M, et al. Balloon dilation of ileocolonic strictures in Crohn's disease. Endoscopy. 2004;36:1001-1007.
37. Connell WR, Sheffield JP, Kamm MA, et al. Lower gastrointestinal malignancy in Crohn's disease. Gut. 1994;35:347-352.
38. Rutter MD, Saunders BP, Schofield G, et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut. 2004;53:256-260.
39. Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology. 2003;124:880-888.